Back to overview

Systematic nuclide therapy with recombinant 67-Cu-labeled chCE7 antibodies: Therapeutic efficacy and investigations of tumor responses with PET imaging.

Applicant Novak-Hofer Ilse
Number 100200
Funding scheme Project funding (Div. I-III)
Research institution Paul Scherrer Institut
Institution of higher education Paul Scherrer Institute - PSI
Main discipline Experimental Cancer Research
Start/End 01.06.2003 - 31.05.2006
Approved amount 191'090.00
Show all

Keywords (6)

Radioimmunotherapy; recombinant antibody fragments; protein production in mammalian cells; 67-Cu labeling; PET imaging; tumor heterogeneity

Responsible applicant and co-applicants


Name Institute